Abstract
Translocation of the Myc gene on chromosome 8q24 to an immunoglobulin gene segment on chromosomes 14q32, 22q11 or 2p12 is believed to be the central event in the pathogenesis of Burkitt’s lymphoma (Dalla-Favera et al. 1982). The molecular heterogeneity of Myc translocations in Burkitt’s lymphoma, suggests that there may be several mechanisms that account for the resulting deregulation of Myc gene transcription, and the consequent abnormalities in cell growth regulation that lead to neoplasia. For example, in many cases of Burkitt’s lymphoma, the transcriptional enhancer of the immunoglobulin heavy chain gene, Eμ, is located on the same chromosome as the translocated Myc gene, suggesting that it may be responsible for activating Myc transcription (Taub et al. 1982). In other cases, however, Eμ and Myc are located on different chromosomes (Rabbitts et al. 1983), and other mechanisms must operate. In sporadic Burkitt’s lymphomas the breakpoints on chromosome 8q24 frequently occur in intron 1 of the Myc gene, separating the oncogene’s regulatory elements from its coding sequences (Pelicci et al. 1986). This suggests that loss of normal regulatory elements may also play a role in abnormal regulation of the translocated oncogene (Taub et al. 1984; Bentley and Groudine 1988; Hann et al. 1988).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albert T, Urlbauer B, Kohlhuber F, Hammersen B, Eick D (1994) Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt’s lymphoma cell lines. Oncogene 9: 759–63
Battey J, Moulding C, Taub R, Murphy W, Stewart T, Potter H, Lenoir G, LederP (1983) The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell 34: 779–87
BentleyDL, GroudineM (1988) Sequence requirements for premature termination of transcription in the human c-myc gene. Cell 53: 245–56
Care A, Cianetti L, Giampaolo A, Sposi NM, Zappavigna V, Mavilio F, AlimenaG, AmadojiS, MandelliF, Peschle C (1986) Translocation of c-myc into the immunoglobulin heavy-chain locus in human acute B-cell leukemia. A molecular analysis. Embo J 5: 905 - 11
Cesarman E, Dalla-Favera R, Bentley D, Groudine M (1987) Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 238: 1272–5
Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM (1982) Human c-myc one gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Nad Acad Sci U S A 79: 7824–7
FearonER, Finkel T, Gillison ML, Kennedy SP, CasellaJF, TomaselliGF, Morrow JS, Dang CV (1992) Karyoplasmic interaction selection strategy: a general strategy to detect protein-protein interactions in mammalian cells. Proc Natl Acad Sci USA 89: 7958–62
Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-FaveraR (1994) Binding and suppression of the Myc transcriptional activation domain by p 107. Science 264: 251–4
Hann SR, King MW, Bentley DL, Anderson CW, Eisenman RN (1988) A non-AUG translational initiation in c-mycexon 1 generates an N-terminally distinct protein whose synthesis is disrupted in Burkitt’s lymphomas. Cell 52: 185–95
Hateboer G, Timmers HT, Rustgi AK, Billaud M, Van’t Veer LJ, Bernards R (1993) TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus El A protein. Proc Nad Acad Sci U S A 90: 8489–93
Kato GJ, Barrett J, Villa GM, Dang CV (1990) An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol 10: 5914–20
Lutterbach B, Hann SR (1994) Hierarchical phosphorylation at N-terminal transformation-sensitive sites in c-Myc protein is regulated by mitogens in mitosis. Mol Cell Bio in press:
Maheswaran S, Lee H, Sonenshein GE (1994) Intracellular association of the protein product of the c-myc oncogene with the TATA-binding protein. Mol Cell Biol 14: 1147 - 52
Murphy W, SaridJ, Taub R, VasicekT, BatteyJ, Lenoir G, LederP (1986) A translocated human c-myc oncogene is altered in a conserved coding sequence. Proc Natl Acad Sci U S A 83: 2939–43
Nisson PE, RashtchianA, Wktkins PC (1991) Rapid and efficient cloning of Alu-PCR products using uracil DNA glycosylase. PCR Methods Appl 1: 120–3
Pelicci PG, Knowles D, Magrath I, Dalla-Favera R (1986) Chromosomal breakpoints and structural alterations of the c-myc locus differ in endemic and sporadic forms of Burkitt lymphoma. Proc Nad Acad Sci U S A 83: 2984–8
Rabbitts TH, Forster A, BaerR, Hamlyn PH (1983) Transcription enhancer identified near the human C mu immunoglobulin heavy chain gene is unavailable to the translocated c-myc gene in a Burkitt lymphoma. Nature 306: 806–9
Rabbitts TH, Forster A, Hamlyn P, BaerR (1984) Effect of somatic mutation within translocated c-myc genes in Burkitt’s lymphoma. Nature 309: 592–7
Rabbitts TH, Hamlyn PH, Baer R (1983) Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature 306:760–5
Showe LC, Ballantine M, Nishikura K, Erikson J, Kaji H, Croce CM (1985) Cloning and sequencing of a c-myc oncogene in a Burkitt’s lymphoma cell line that is translocated to a germ line alpha switch region. Mol Cell Biol 5: 501–9
Spencer CA, LeStrange RC, Novak U, Hayward WS, Groudine M (1990) The block to transcription elongation is promoter dependent in normal and Burkitt’s lymphoma c-myc alleles. Genes Dev 4: 75–88
Stanton LW, Fahrlander PD, Tesser PM, Marcu KB (1984) Nucleotide sequence comparison of normal and translocated murine c-myc genes. Nature 310: 423–5
Szajnert MF, Saule S, Bornkamm GW, Wajcman H, Lenoir GM, Kaplan JC (1987) Clustered somatic mutations in and around first exon of non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation. Nucleic Acids Res 15: 4553–65
Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P (1982) Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A 79: 7837–41
Taub R, Moulding C, BatteyJ, Murphy W, VasicekT, Lenoir GM, LederP (1984) Activation and somatic mutation of the translocated c-myc gene in burkitt lymphoma cells. Cell 36: 339–48
Yano T, Sander CA, Clark HM, Dolezal MV, Jaffe ES, Raffeld M (1993) Clustered mutations in the second exon of the Myc gene in sporadic Burkitt’s lymphoma. Oncogene 8: 2741–8
Yano T, van Krieken JHJM, Magrath IT, Longo DL, Jaffe ES, Raffeld M (1992) Histogenetic correlations between subcategories of small noncleaved cell lymphomas. Blood 79: 1282–90
Zajac-Kaye M, Gelmann EP, Levens D (1988) A point mutation in the c-myc locus of a Burkitt lymphoma abolishes binding of a nuclear protein. Science 240: 1776–80
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Raffeld, M. et al. (1995). Clustered Mutations in the Transcriptional Activation Domain of Myc in 8q24 Translocated Lymphomas and their Functional Consequences. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1994. Current Topics in Microbiology and Immunology, vol 194. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79275-5_31
Download citation
DOI: https://doi.org/10.1007/978-3-642-79275-5_31
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-79277-9
Online ISBN: 978-3-642-79275-5
eBook Packages: Springer Book Archive